Doseology Sciences Inc.

Doseology Sciences Inc.

DOSEF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$771.52K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Doseology Sciences Inc.Doseology Sciences Inc.-0.6--1413%--
$0.08

Current Fair Value

13.2% downside

Overvalued by 13.2% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$771,520.00
Enterprise Value$576,622.00
Earnings per Share$-0.21
Beta2.29
Outstanding Shares8,011,630

Return

Return on Equity-1413.48%ROE
Return on Assets-629.78%
Return on Invested Capital-1308.68%

Valuation & Multiples

P/E Ratio-0.55P/E Ratio
PEG-0.23PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue5.36
Enterprise Value to EBIT-0.36
Enterprise Value to Net Income-1
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Doseology Sciences Inc.

3 employees
CEO: Christopher Jackson

Doseology Sciences Inc. is a Canadian firm dedicated to the cultivation and extraction of ingredients for both nutraceutical and pharmaceutical applications. The company's primary focus lies in the research, development, and commercializ...